Greenfield Advisors Launches Pharmaceutical and Medical Royalty Valuation Practice
CARTERSVILLE, GA and SEATTLE, WA (PRWEB) January 13, 2016 -- Greenfield Advisors now provides expert medical royalty valuation. The financial and real estate consulting firm saw a need for such services after meeting with several executives in the medical and pharmaceutical industries.
“We heard it time and again that investors, biotechnology companies, academic institutions and hospitals needed a reliable way to value pharmaceutical royalties,” said Dr. Clifford Lipscomb, Director of Economic Research at Greenfield Advisors. “We have built our reputation on our valuation skills, and we have a staff that has a background in the medical royalty industry. It’s really a perfect fit.”
Greenfield Advisors identified a need for holders and recipients of pharmaceutical and medical technology royalties to receive valuation advice in a non-transactional setting. Investors, universities and other research institutions, biotechnology companies, and pharmaceutical companies can make use of objective, independent valuation for board reviews and mark-to-market.
Greenfield also serves venture capital and private equity firms who are seeking to enter the market by providing them with expertise in the fundamentals of the sourcing and valuation process, as well as structuring and valuation for specific transactions.
However, it’s not just medical royalties that Greenfield can value. The firm’s 40-year history is built on the expertise of its team of experts who can value a wide range of assets, from contaminated properties to trophy properties, archaeological and paleontological resources, and now pharmaceutical royalties.
“We look forward to working with our clients and providing them top-level analysis on all of their projects,” Dr. Lipscomb said.
Founded in 1976, Greenfield Advisors is a consulting firm specializing in complex real estate issues. Best known for its work in high-profile litigation and trophy property valuation, Greenfield Advisors addresses a broad range of issues in its projects, including feasibility studies, market research, valuation, business plans, and economic modeling. Greenfield’s analysts provide clients across the country and all over the world with the information and experience to make informed decisions. Learn more about Greenfield Advisors by visiting http://www.greenfieldadvisors.com or by calling 206-623-2935.
# # #
Joe Schulman, Greenfield Advisors, http://www.greenfieldadvisors.com, +1 678-315-3745, [email protected]
Share this article